Ascendia

Today kicked off day one of our two-day workshop, Recent Advances in Drug Delivery Technologies for Bioavailability Enhancement! Attendees and presenters enjoyed a morning of engaging interactive discussions on innovations that are driving the drug development landscape. Thank you to this morning’s speakers: Robert (Bob) Prud'homme, PhD, Princeton University James J Moon, PhD, University of Michigan Liping Zhou, PhD, Astra Zeneca Maria (Mandy) Janssen, PhD, Nanoimaging Services Mansoor Amiji, PhD, Northeastern University Jayachandra Babu Ramapuram, PhD, Auburn University #AscendiaPharma #CDMO #AscendiaPharmaWorkshop

In less than a week, leaders in the #pharmaceutical and #biologics market will gather in Princeton, NJ to present advances in #drugdevelopment. Ascendia Pharma’s two-day technical workshop Recent Advances in Drug Delivery Technologies for Bioavailability Enhancement will feature 18 speakers from academia and industry, each offering unique insight and research that are advancing drug development.   Register and find more information here: https://bit.ly/3VQRLYU #drugformulatioin #CDMO #drugdelivery

Dr. Shaukat Ali, senior director of scientific affairs and technical marketing at Ascendia, and Dr. John Carpenter, professor emeritus of pharmaceutical sciences at the University of Colorado, recently conducted a webinar on lyophilized formulations of #biological molecules (eg, proteins). The presentation examined the main steps in the #lyophilization process and the mechanisms by which excipients provide stabilization to protein during freezing, drying, storage, and reconstitution. Watch the webinar here: https://lnkd.in/eGdpu5kE #DrugDevelopment #CDMO

We are less than one month away from Ascendia® Pharma’s two-day technical workshop Recent Advances in Drug Delivery Technologies for Bioavailability Enhancement. Join us and learn from esteemed members of academia and the #pharmaindustry as they discuss the latest trends and technologies shaping #drugdevelopment. Register and find more information here: https://bit.ly/3VQRLYU #Ascendia

We’re less than a week away from ChemOutsourcing Week September 3-6 in Parsippany, NJ. Ascendia® Pharma Chief Business Officer, Robert Bloder will take part in a panel discussion on Thursday, September 5. It is entitled Update: Latest Commercial Strategy 505(b)(2) and will be held from 10:30 - 11:15 AM.    Additionally, Ascendia Pharmaceuticals CEO and Founder, Dr. Jim Jingjun Huang, Ph.D., and Senior Director of Scientific Affairs and Technical Marketing, Dr. Shaukat Ali, will also be at ChemOutsourcing. They are ready to discuss how Ascendia can overcome your most challenging drug formulations to make the Impossible Possible.                                                                                        Register here: https://lnkd.in/e3cfa2K7   Want to talk to our team? Contact danni.song@ascendiapharma.com to schedule a meeting.

Ascendia®’s enabling technology, LipidSol®, is well suited for vaccines and large molecules requiring the #lyophilization method, a 3-step process that could take 24+ hours. These steps include: 1. Freezing 2. Primary drying (sublimation) 3. Secondary drying (residual moisture removal)   This topic will be discussed in the next Formulation Forum published by Drug Development & Delivery. Dr. Jim Jingjun Huang, Ph.D., founder and CEO of Ascendia Pharmaceuticals, and Dr. Shaukat Ali, senior director of scientific affairs and technical marketing at Ascendia, co-authored the column on an emerging issue in the #drugdevelopment of modern #pharmaceuticals.    Learn more about LipidSol: https://lnkd.in/eYUNvKBN

Over 80% of molecules in new chemical entities are poorly soluble and have less bioavailability. The instability caused by these factors creates a barrier for new #drugdevelopment. #Lyophilization technology is an enabler for stable formulations of small and large molecules. It is a method to enhance the shelf-life and enable ambient temperature storage conditions for life-saving medicines.   Ascendia® is expert in lyophilization or #freezedrying methods. This expertise, along with our nanotechnologies and state-of-the-art U.S.-based manufacturing facility have allowed us to development formulations where others have failed.   Contact us to discuss how we can help with your #drugdevelopment projects: https://lnkd.in/eRQV_-5G

Join Ascendia Pharmaceutical’s CEO and Founder, Dr. Jim Jingjun Huang, Ph.D., Senior Director of Scientific Affairs and Technical Marketing, Dr. Shaukat Ali, and Chief Business Officer, Robert Bloder at ChemOutsouring Week September 3-6 in Parsippany, NJ.   Robert Bloder will be moderating a panel discussion from 10:30AM – 11:15AM on September 5, where he will lead a discussion on the latest perspectives and strategies on FDA 505(b)(2) applications.                                                                                          Register here: https://lnkd.in/e3cfa2K7   Contact danni.song@ascendiapharma.com to set up a meeting with our team.

Manufacturing #emulsions and #microemulsions can often prove to be challenging. Using state-of-the-art manufacturing systems, Ascendia® is meeting these obstacles. Ascendia employs its latest Cytiva microfluidic systems to generate polymeric and lipid nanoparticles (LNPs). The state-of-the-art equipment, including NanoAssemblr™ Ignite™, NanoAssemblr™ Blaze™ and NanoAssemblr™ GMP systems, can help drug development teams in need of early- and late-phase #cGMP manufacturing of drugs encapsulated in liposomes, #LNPs, polymeric micelles, and lipid-based emulsions and microemulsions. Read our blog on the challenges associated with emulsions and microemulsions in manufacturing, and approaches to overcome them: https://bit.ly/3WK9Et3 #drugdevelopment

We are almost one month away from Ascendia® Pharma’s two-day technical workshop Recent Advances in Drug Delivery Technologies for Bioavailability Enhancement.   It’s not too late to register for the workshop where you will learn about the latest trends and technologies shaping #drugdevelopment from esteemed members of academia and the #pharma industry.   RSVP today and find more information here: https://bit.ly/3VQRLYU #Ascendia #AscendiaPharma #biologics